SOMERSET, New Jersey, June 27 /PRNewswire/ --

inVentiv Health, Inc. (Nasdaq: VTIV) announced today that it has signed a
definitive agreement to acquire Chandler Chicco Agency (CCA), the world's
largest privately-held healthcare public relations firm. CCA will operate
within the inVentiv Communications division, which provides a full suite of
integrated healthcare marketing and communications solutions.

Under the terms of the agreement, inVentiv will acquire CCA for US$65
million in cash and stock, plus earn-out payments for exceeding specified
financial targets. The transaction, which is subject to receipt of
Hart-Scott-Rodino approval and other customary closing conditions, is
expected to close in the third quarter. The acquisition is expected to be
immediately accretive to inVentiv's earnings.

Chandler Chicco Agency is a full-service, global healthcare public
relations firm. Founded in 1995 by healthcare public relations veterans
Robert Chandler and Gianfranco Chicco, CCA provides clients with
insight-driven communications strategies that - through innovative and
powerful programs - build, enhance or protect brand value and further public
affairs agendas. The company's client roster includes many of the world's top
pharmaceutical companies including Allergan, GlaxoSmithKline, and Novartis.
For CCA, 2007 has been a banner year winning multiple awards - two awards
from PR Week, Midsize Agency of the Year and Agency of the Year, and two
awards from the Holmes Report, Specialty Agency of the Year and Healthcare
Agency of the Year.

"In today's competitive marketplace, our pharmaceutical clients are
increasingly turning to public relations to build awareness, credibility and
loyalty for their products," said Eran Broshy, Chairman and CEO of inVentiv
Health. "Chandler Chicco Agency has established an unmatched reputation in
the healthcare PR industry that is distinguished by solid long-term client
relationships and an impressive history of growth. Adding CCA to our
portfolio of services will significantly expand our PR offering, while also
broadening our global capabilities."

CCA principal and co-founder Robert Chandler said, "Our successes over
the past 12 years have been unprecedented and the next 12 will be, too,
because we're putting into place a smart global growth strategy that will
lead us to even greater achievement."

"This partnership allows us to scale up globally at warp speed and with
greater authority, while maintaining our culture of success," added
Gianfranco Chicco, co-founder and CCA principal. "It is an ideal
partnership."

Upon the close of the transaction, CCA will become a wholly-owned
subsidiary of inVentiv Health and operate within the inVentiv Communications
division. The CCA brand and all the other brands that are part of the
Chandler Chicco Companies, including Biosector2, BrandTectonics, CCA
Advertising, Determinus, Litmus and 'nition will remain, and Robert Chandler
and Gianfranco Chicco will continue to lead the business, reporting into
William O'Donnell, President and COO of inVentiv Communications.

AdMedia Partners acted as financial advisor to Chandler Chicco Agency in
connection with this transaction.

Conference Call Details

inVentiv will host a conference call today, June 26, 2007, at 5:30pm EDT
to discuss its acquisition of Chandler Chicco Agency. Call In Number:
+1-800-358-8448 (Domestic) or +1-706-634-1367 (International) Live and 
Archived Webcast: www.inventivhealth.com

A replay of the call will be available immediately following the call
through July 3, 2007 at +1-800-642-1687. The conference ID number for the 
replay is 4413978.

About Chandler Chicco Agency

Chandler Chicco Agency is the world's largest independent healthcare
specialist public relations agency with offices in New York, London,
Washington D.C., Los Angeles and Paris. CCA offers strategic public relations
and communications counsel to clients that include hospitals, NGOs,
healthcare associations, coalitions and most of the world's largest
pharmaceutical companies. CCA is the flagship company for Chandler Chicco
Companies; other brands under the Chandler Chicco Companies umbrella include
Biosector2, BrandTectonics, CCA Advertising, Determinus, Litmus and 'nition.
For more information, visit www.ccapr.com.

About inVentiv Health

inVentiv Health, Inc. (NASDAQ: VTIV) is the leading provider of
commercialization and complementary services to the global pharmaceutical,
life sciences and biotechnology industries. inVentiv delivers its customized
clinical, sales, marketing and communications solutions through its three
core business segments: inVentiv Clinical, inVentiv Communications and
inVentiv Commercial. inVentiv Health currently works with over 200 unique
pharmaceutical, biotech and life sciences clients, including all top 20
global pharmaceutical companies. For more information, visit
www.inventivhealth.com.

This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks that may cause inVentiv Health's
performance to differ materially. Such risks include, without limitation:
changes in trends in the pharmaceutical industry or in pharmaceutical
outsourcing; our ability to compete successfully with other services in the
market; our ability to maintain large client contracts or to enter into new
contracts; uncertainties related to future incentive payments; and, our
ability to operate successfully in new lines of business. Readers of this
press release are referred to documents filed from time to time by inVentiv
Health Inc. with the Securities and Exchange Commission for further
discussion of these and other factors.

Web site: http://www.inventivhealth.com